Showing results (481-490 of 496) with videos related to
Sort By:
Pageof 50
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.Journal of the American College of Cardiology|September 12, 2013
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertensionMarkus P Schlaich, Roland E Schmieder, George Bakris, et al.Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.European Journal of Preventive Cardiology|February 25, 2026
Technical Aspects and Clinical Relevance of Cuffless Devices for Blood Pressure Measurement. A Scientific Statement of the ESC Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESCGianfranco Parati, Juan Eugenio Ochoa, Ana Abreu, et al.American Heart Journal|February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Pieter Smits, Pascal Vranckx, et al.Circulation|March 14, 2022
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research ConsortiumDavid E Kandzari, Felix Mahfoud, Michael A Weber, et al.Lancet (London, England)|April 3, 2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E Kandzari, et al.Lancet (London, England)|September 2, 2017
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R Townsend, Felix Mahfoud, David E Kandzari, et al.European Journal of Heart Failure|September 27, 2017
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyMarc van Bilsen, Hitesh C Patel, Johann Bauersachs, et al.European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.Pageof 50